These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 19528350)

  • 1. Luminal cathepsin g and protease-activated receptor 4: a duet involved in alterations of the colonic epithelial barrier in ulcerative colitis.
    Dabek M; Ferrier L; Roka R; Gecse K; Annahazi A; Moreau J; Escourrou J; Cartier C; Chaumaz G; Leveque M; Ait-Belgnaoui A; Wittmann T; Theodorou V; Bueno L
    Am J Pathol; 2009 Jul; 175(1):207-14. PubMed ID: 19528350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracolonic infusion of fecal supernatants from ulcerative colitis patients triggers altered permeability and inflammation in mice: role of cathepsin G and protease-activated receptor-4.
    Dabek M; Ferrier L; Annahazi A; Bézirard V; Polizzi A; Cartier C; Leveque M; Roka R; Wittmann T; Theodorou V; Bueno L
    Inflamm Bowel Dis; 2011 Jun; 17(6):1409-14. PubMed ID: 21560201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal proteases from diarrheic-IBS and ulcerative colitis patients exert opposite effect on visceral sensitivity in mice.
    Annaházi A; Gecse K; Dabek M; Ait-Belgnaoui A; Rosztóczy A; Róka R; Molnár T; Theodorou V; Wittmann T; Bueno L; Eutamene H
    Pain; 2009 Jul; 144(1-2):209-17. PubMed ID: 19450926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased faecal serine protease activity in diarrhoeic IBS patients: a colonic lumenal factor impairing colonic permeability and sensitivity.
    Gecse K; Róka R; Ferrier L; Leveque M; Eutamene H; Cartier C; Ait-Belgnaoui A; Rosztóczy A; Izbéki F; Fioramonti J; Wittmann T; Bueno L
    Gut; 2008 May; 57(5):591-9. PubMed ID: 18194983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of intestinal inflammation in mouse by activation of proteinase-activated receptor-2.
    Cenac N; Coelho AM; Nguyen C; Compton S; Andrade-Gordon P; MacNaughton WK; Wallace JL; Hollenberg MD; Bunnett NW; Garcia-Villar R; Bueno L; Vergnolle N
    Am J Pathol; 2002 Nov; 161(5):1903-15. PubMed ID: 12414536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colonic luminal proteases activate colonocyte proteinase-activated receptor-2 and regulate paracellular permeability in mice.
    Róka R; Demaude J; Cenac N; Ferrier L; Salvador-Cartier C; Garcia-Villar R; Fioramonti J; Bueno L
    Neurogastroenterol Motil; 2007 Jan; 19(1):57-65. PubMed ID: 17187589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil-mediated activation of epithelial protease-activated receptors-1 and -2 regulates barrier function and transepithelial migration.
    Chin AC; Lee WY; Nusrat A; Vergnolle N; Parkos CA
    J Immunol; 2008 Oct; 181(8):5702-10. PubMed ID: 18832729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exposure of Colon-Derived Epithelial Monolayers to Fecal Luminal Factors from Patients with Colon Cancer and Ulcerative Colitis Results in Distinct Gene Expression Patterns.
    Magnusson MK; Bas Forsberg A; Verveda A; Sapnara M; Lorent J; Savolainen O; Wettergren Y; Strid H; Simrén M; Öhman L
    Int J Mol Sci; 2024 Sep; 25(18):. PubMed ID: 39337373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil serine proteinases activate human nonepithelial cells to produce inflammatory cytokines through protease-activated receptor 2.
    Uehara A; Muramoto K; Takada H; Sugawara S
    J Immunol; 2003 Jun; 170(11):5690-6. PubMed ID: 12759451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protease activated receptor 2: a new target for IBS treatment.
    Bueno L
    Eur Rev Med Pharmacol Sci; 2008 Aug; 12 Suppl 1():95-102. PubMed ID: 18924448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory mediators modulate thrombin and cathepsin-G signaling in human bronchial fibroblasts by inducing expression of proteinase-activated receptor-4.
    Ramachandran R; Sadofsky LR; Xiao Y; Botham A; Cowen M; Morice AH; Compton SJ
    Am J Physiol Lung Cell Mol Physiol; 2007 Mar; 292(3):L788-98. PubMed ID: 17142351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protease signaling through protease activated receptor 1 mediate nerve activation by mucosal supernatants from irritable bowel syndrome but not from ulcerative colitis patients.
    Buhner S; Hahne H; Hartwig K; Li Q; Vignali S; Ostertag D; Meng C; Hörmannsperger G; Braak B; Pehl C; Frieling T; Barbara G; De Giorgio R; Demir IE; Ceyhan GO; Zeller F; Boeckxstaens G; Haller D; Kuster B; Schemann M
    PLoS One; 2018; 13(3):e0193943. PubMed ID: 29529042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteinase-activated receptor-2-induced colonic inflammation in mice: possible involvement of afferent neurons, nitric oxide, and paracellular permeability.
    Cenac N; Garcia-Villar R; Ferrier L; Larauche M; Vergnolle N; Bunnett NW; Coelho AM; Fioramonti J; Bueno L
    J Immunol; 2003 Apr; 170(8):4296-300. PubMed ID: 12682265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A low dose of fermented soy germ alleviates gut barrier injury, hyperalgesia and faecal protease activity in a rat model of inflammatory bowel disease.
    Moussa L; Bézirard V; Salvador-Cartier C; Bacquié V; Lencina C; Lévêque M; Braniste V; Ménard S; Théodorou V; Houdeau E
    PLoS One; 2012; 7(11):e49547. PubMed ID: 23166707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of Fecal Epithelial Heparanase mRNA Is Associated with Increased Ulcerative Colitis Activity and Cancerization Risk.
    Cui Y; Zhang J; Chen Y; Chen LG
    Dig Dis Sci; 2021 May; 66(5):1488-1498. PubMed ID: 32445051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation.
    Vivinus-Nébot M; Frin-Mathy G; Bzioueche H; Dainese R; Bernard G; Anty R; Filippi J; Saint-Paul MC; Tulic MK; Verhasselt V; Hébuterne X; Piche T
    Gut; 2014 May; 63(5):744-52. PubMed ID: 23878165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot study of fecal serine-protease activity: a pathophysiologic factor in diarrhea-predominant irritable bowel syndrome.
    Róka R; Rosztóczy A; Leveque M; Izbéki F; Nagy F; Molnár T; Lonovics J; Garcia-Villar R; Fioramonti J; Wittmann T; Bueno L
    Clin Gastroenterol Hepatol; 2007 May; 5(5):550-5. PubMed ID: 17336590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated human beta-defensin-2 levels indicate an activation of the innate immune system in patients with irritable bowel syndrome.
    Langhorst J; Junge A; Rueffer A; Wehkamp J; Foell D; Michalsen A; Musial F; Dobos GJ
    Am J Gastroenterol; 2009 Feb; 104(2):404-10. PubMed ID: 19174795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cathepsin S is activated during colitis and causes visceral hyperalgesia by a PAR2-dependent mechanism in mice.
    Cattaruzza F; Lyo V; Jones E; Pham D; Hawkins J; Kirkwood K; Valdez-Morales E; Ibeakanma C; Vanner SJ; Bogyo M; Bunnett NW
    Gastroenterology; 2011 Nov; 141(5):1864-74.e1-3. PubMed ID: 21802389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophil Extracellular Traps Sustain Inflammatory Signals in Ulcerative Colitis.
    Dinallo V; Marafini I; Di Fusco D; Laudisi F; Franzè E; Di Grazia A; Figliuzzi MM; Caprioli F; Stolfi C; Monteleone I; Monteleone G
    J Crohns Colitis; 2019 May; 13(6):772-784. PubMed ID: 30715224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.